Introduction
The background of prediabetes mellitus affecting 96 million people and the rising diabetes mellitus prevalence in the United States motivates us to advocate for the adoption of an evidence-based program to prevent diabetes mellitus in groups of individuals with a history of gestational diabetes mellitus (GDM). After a pregnancy complicated by GDM, during the immediate postpartum period or initial healthcare encounter, we suggest that the affected person participates in a Centers for Disease Control and Prevention (CDC)–recognized Diabetes Prevention Program (DPP) to decrease their risk of type 2 diabetes mellitus (T2D) and conceivably lower their risk of recurrent GDM.

Background
In January of 2021, the CDC reported that of the US population, 37.3 million (11.3%) and 96 million (23%) people were living with diabetes or prediabetes mellitus, respectively.1 In 2001, Tuomilehto2 reported the results of the Finnish Diabetes Prevention Study that found that T2D could be prevented if high-risk patients adopted prescribed lifestyle changes. A 10-year follow-up of the adoption of these lifestyle changes was evaluated in the National Institute of Diabetes and Digestive and Kidney Diseases–sponsored CDC DPP that was a randomized, controlled clinical trial conducted at 27 US clinical centers enrolling >3230 individuals. This trial demonstrated that individuals at high risk for T2D, who achieve significant weight reduction by participating in a lifestyle modification program (through increased physical activity and dietary changes), could prevent or postpone the onset of T2D.




Sources - https://www.sciencedirect.com/science/article/pii/S2666577822000983